SCHEMBL22962197

SCHEMBL22962197

CCCCCCCC(CCCCCC)N1CCC(C)(N)C1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 6/20 0.36
CHRM2 P08172 1/20 0.36
HTR1A P08908 1/20 0.36
ADRA2A P08913 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
CHRM1 P11229 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
DRD3 P35462 1/20 0.36
SLC6A3 Q01959 1/20 0.36
KCNH2 Q12809 1/20 0.36
CYP2D6 P10635 1/20 0.36
OPRD1 P41143 4/20 0.35
OPRK1 P41145 4/20 0.35
OPRL1 P41146 4/20 0.35
FDPS P14324 3/20 0.31
SPHK1 Q9NYA1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22962035 1.00 OPRM1 (0.36) OPRM1CHRM2HTR1AADRA2AADORA3
SCHEMBL22962175 1.00 OPRM1 (0.36) OPRM1CHRM2HTR1AADRA2AADORA3
SCHEMBL22962165 1.00 OPRM1 (0.36) OPRM1CHRM2HTR1AADRA2AADORA3
SCHEMBL23733433 0.83 OPRM1 (0.37) OPRM1OPRD1OPRK1OPRL1FDPS
SCHEMBL22446841 0.80 OPRM1 (0.41) OPRM1OPRD1OPRK1OPRL1FDPS
SCHEMBL22990416 0.80 OPRM1 (0.33) OPRM1CHRM2HTR1AADRA2AADORA3
SCHEMBL22990197 0.80 OPRM1 (0.36) OPRM1CYP2D6OPRD1OPRK1OPRL1
SCHEMBL24425014 0.80 OPRM1 (0.33) OPRM1CHRM2HTR1AADRA2AADORA3
SCHEMBL22962267 0.80 OPRM1 (0.36) OPRM1CYP2D6OPRD1OPRK1OPRL1
SCHEMBL22990194 0.80 OPRM1 (0.33) OPRM1CHRM2HTR1AADRA2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210040087-A1 SOMATOSTATIN MODULATORS AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210040087-A1 SOMATOSTATIN MODULATORS AND USES THEREOF SSTR5, SSTR2, SSTR4 OPRM1 467/4885CHRM2 865/4885HTR1A 245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.